Loading…
Vancomycin and cardiac arrest in the infant
Different adverse effects induced by vancomycin bolus infusion are described, but cardiac arrest seems rare, in children as in adults. Two infants, 5 and 12 months old, were admitted after cardiac arrest, following vancomycin bolus infusion in excessive dose. They recovered after prompt resuscitatio...
Saved in:
Published in: | Archives de pédiatrie : organe officiel de la Société française de pédiatrie 1998-05, Vol.5 (5), p.521 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | fre |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 5 |
container_start_page | 521 |
container_title | Archives de pédiatrie : organe officiel de la Société française de pédiatrie |
container_volume | 5 |
creator | Trentesaux, A S Bednarek, N Morville, P |
description | Different adverse effects induced by vancomycin bolus infusion are described, but cardiac arrest seems rare, in children as in adults.
Two infants, 5 and 12 months old, were admitted after cardiac arrest, following vancomycin bolus infusion in excessive dose. They recovered after prompt resuscitation and their short term follow-up was normal.
Two mechanisms are invoked: anaphylactic shock and direct cardiovascular toxicity. Both are dose- and infusion rate-dependent, and probably intersubject dependent. Usually, cardiac arrest is promptly reversed by adequate resuscitation. The rules of prescription are: adequate dilution and slow rate of infusion. If any adverse effect occurred, preventive antihistaminic drug therapy should be advised. |
doi_str_mv | 10.1016/S0929-693X(99)80318-2 |
format | article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_9759187</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>9759187</sourcerecordid><originalsourceid>FETCH-LOGICAL-p138t-f96e336213dce660d794b5d6bf3de59ca11bb7c61cd6169f03f25bd09d6bc94f3</originalsourceid><addsrcrecordid>eNo9jktLw1AQRu9CqbX6EwpZKnJ1JtNM7iylWBUKLnzgrtwnRkwMN3HRf2_A4urA4ePwKbVEuEZAvnkGKUWz0PuFyKUBQqPLIzX_1yfqdBg-AcCAoZmaSV0Jmnqurt5s57_bvW-6wnah8DaHxvrC5hyHsZjs-BEnJNuNZ-o42a8hnh-4UK-bu5f1g94-3T-ub7e6RzKjTsKRiEuk4CMzhFpWrgrsEoVYibeIztWe0QdGlgSUysoFkGniZZVooZZ_3f7HtTHs-ty0Nu93h9P0C0Q8QqQ</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Vancomycin and cardiac arrest in the infant</title><source>Elsevier</source><creator>Trentesaux, A S ; Bednarek, N ; Morville, P</creator><creatorcontrib>Trentesaux, A S ; Bednarek, N ; Morville, P</creatorcontrib><description>Different adverse effects induced by vancomycin bolus infusion are described, but cardiac arrest seems rare, in children as in adults.
Two infants, 5 and 12 months old, were admitted after cardiac arrest, following vancomycin bolus infusion in excessive dose. They recovered after prompt resuscitation and their short term follow-up was normal.
Two mechanisms are invoked: anaphylactic shock and direct cardiovascular toxicity. Both are dose- and infusion rate-dependent, and probably intersubject dependent. Usually, cardiac arrest is promptly reversed by adequate resuscitation. The rules of prescription are: adequate dilution and slow rate of infusion. If any adverse effect occurred, preventive antihistaminic drug therapy should be advised.</description><identifier>ISSN: 0929-693X</identifier><identifier>DOI: 10.1016/S0929-693X(99)80318-2</identifier><identifier>PMID: 9759187</identifier><language>fre</language><publisher>France</publisher><subject>Anaphylaxis - chemically induced ; Anti-Bacterial Agents - administration & dosage ; Anti-Bacterial Agents - adverse effects ; Female ; Heart Arrest - chemically induced ; Humans ; Infant ; Infusions, Intravenous ; Male ; Vancomycin - administration & dosage ; Vancomycin - adverse effects</subject><ispartof>Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 1998-05, Vol.5 (5), p.521</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9759187$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Trentesaux, A S</creatorcontrib><creatorcontrib>Bednarek, N</creatorcontrib><creatorcontrib>Morville, P</creatorcontrib><title>Vancomycin and cardiac arrest in the infant</title><title>Archives de pédiatrie : organe officiel de la Société française de pédiatrie</title><addtitle>Arch Pediatr</addtitle><description>Different adverse effects induced by vancomycin bolus infusion are described, but cardiac arrest seems rare, in children as in adults.
Two infants, 5 and 12 months old, were admitted after cardiac arrest, following vancomycin bolus infusion in excessive dose. They recovered after prompt resuscitation and their short term follow-up was normal.
Two mechanisms are invoked: anaphylactic shock and direct cardiovascular toxicity. Both are dose- and infusion rate-dependent, and probably intersubject dependent. Usually, cardiac arrest is promptly reversed by adequate resuscitation. The rules of prescription are: adequate dilution and slow rate of infusion. If any adverse effect occurred, preventive antihistaminic drug therapy should be advised.</description><subject>Anaphylaxis - chemically induced</subject><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Anti-Bacterial Agents - adverse effects</subject><subject>Female</subject><subject>Heart Arrest - chemically induced</subject><subject>Humans</subject><subject>Infant</subject><subject>Infusions, Intravenous</subject><subject>Male</subject><subject>Vancomycin - administration & dosage</subject><subject>Vancomycin - adverse effects</subject><issn>0929-693X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNo9jktLw1AQRu9CqbX6EwpZKnJ1JtNM7iylWBUKLnzgrtwnRkwMN3HRf2_A4urA4ePwKbVEuEZAvnkGKUWz0PuFyKUBQqPLIzX_1yfqdBg-AcCAoZmaSV0Jmnqurt5s57_bvW-6wnah8DaHxvrC5hyHsZjs-BEnJNuNZ-o42a8hnh-4UK-bu5f1g94-3T-ub7e6RzKjTsKRiEuk4CMzhFpWrgrsEoVYibeIztWe0QdGlgSUysoFkGniZZVooZZ_3f7HtTHs-ty0Nu93h9P0C0Q8QqQ</recordid><startdate>199805</startdate><enddate>199805</enddate><creator>Trentesaux, A S</creator><creator>Bednarek, N</creator><creator>Morville, P</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>199805</creationdate><title>Vancomycin and cardiac arrest in the infant</title><author>Trentesaux, A S ; Bednarek, N ; Morville, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p138t-f96e336213dce660d794b5d6bf3de59ca11bb7c61cd6169f03f25bd09d6bc94f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>1998</creationdate><topic>Anaphylaxis - chemically induced</topic><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Anti-Bacterial Agents - adverse effects</topic><topic>Female</topic><topic>Heart Arrest - chemically induced</topic><topic>Humans</topic><topic>Infant</topic><topic>Infusions, Intravenous</topic><topic>Male</topic><topic>Vancomycin - administration & dosage</topic><topic>Vancomycin - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Trentesaux, A S</creatorcontrib><creatorcontrib>Bednarek, N</creatorcontrib><creatorcontrib>Morville, P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Archives de pédiatrie : organe officiel de la Société française de pédiatrie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Trentesaux, A S</au><au>Bednarek, N</au><au>Morville, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vancomycin and cardiac arrest in the infant</atitle><jtitle>Archives de pédiatrie : organe officiel de la Société française de pédiatrie</jtitle><addtitle>Arch Pediatr</addtitle><date>1998-05</date><risdate>1998</risdate><volume>5</volume><issue>5</issue><spage>521</spage><pages>521-</pages><issn>0929-693X</issn><abstract>Different adverse effects induced by vancomycin bolus infusion are described, but cardiac arrest seems rare, in children as in adults.
Two infants, 5 and 12 months old, were admitted after cardiac arrest, following vancomycin bolus infusion in excessive dose. They recovered after prompt resuscitation and their short term follow-up was normal.
Two mechanisms are invoked: anaphylactic shock and direct cardiovascular toxicity. Both are dose- and infusion rate-dependent, and probably intersubject dependent. Usually, cardiac arrest is promptly reversed by adequate resuscitation. The rules of prescription are: adequate dilution and slow rate of infusion. If any adverse effect occurred, preventive antihistaminic drug therapy should be advised.</abstract><cop>France</cop><pmid>9759187</pmid><doi>10.1016/S0929-693X(99)80318-2</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0929-693X |
ispartof | Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 1998-05, Vol.5 (5), p.521 |
issn | 0929-693X |
language | fre |
recordid | cdi_pubmed_primary_9759187 |
source | Elsevier |
subjects | Anaphylaxis - chemically induced Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - adverse effects Female Heart Arrest - chemically induced Humans Infant Infusions, Intravenous Male Vancomycin - administration & dosage Vancomycin - adverse effects |
title | Vancomycin and cardiac arrest in the infant |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T12%3A04%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vancomycin%20and%20cardiac%20arrest%20in%20the%20infant&rft.jtitle=Archives%20de%20p%C3%A9diatrie%20:%20organe%20officiel%20de%20la%20Soci%C3%A9t%C3%A9%20fran%C3%A7aise%20de%20p%C3%A9diatrie&rft.au=Trentesaux,%20A%20S&rft.date=1998-05&rft.volume=5&rft.issue=5&rft.spage=521&rft.pages=521-&rft.issn=0929-693X&rft_id=info:doi/10.1016/S0929-693X(99)80318-2&rft_dat=%3Cpubmed%3E9759187%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p138t-f96e336213dce660d794b5d6bf3de59ca11bb7c61cd6169f03f25bd09d6bc94f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/9759187&rfr_iscdi=true |